Financial Report

Latest NewsStocks

Dr. Reddy’s Q3: 15% Revenue Growth, Profitability Under Scrutiny

Dr Reddy’s Q3 reports highlight 2.5% year-on-year growth amid NRT acquisition Indian pharma leader Dr. Reddy's Labs Q3 results for fiscal year 2024-25 have been released. The reports show high…

Impressive Mobile First Website Builder

Ready for Core Web Vitals, Support for Elementor, With 1000+ Options Allows to Create Any Imaginable Website. It is the Perfect Choice for Professional Publishers.

Explore Now